By Dr. Quoc N. Dang, DO
By the time a patient walks into my office ready to discuss weight loss medication, they have usually spent considerable time researching it on their own. This is generally a good thing. Informed patients ask better questions, engage more actively with their treatment plan, and may be better prepared for the long-term process.
However, the information surrounding GLP-1 medications can be confusing. Patients may arrive with misconceptions that, if not addressed early, can undermine their experience with treatment before it has a chance to work as intended.
After seeing patients through the process of starting, adjusting, and maintaining weight loss medication, I have developed a clear sense of which misunderstandings come up most often. Addressing them before treatment begins can help patients develop realistic expectations and make better-informed decisions.
Table of Contents
Misconception 1: The Medication Does the Work and You Just Wait
This is one of the most problematic expectations a patient can bring into treatment, and it is understandable where it comes from. Results from clinical trials involving GLP-1-based medications can be significant enough to create the impression that taking the medication alone is enough to produce lasting weight loss.
The reality is more collaborative. GLP-1-based medications can reduce appetite, increase feelings of fullness, and influence signals involved in food intake. What they do not automatically do is establish the eating, activity, sleep, and behavioral habits that can help maintain results over time.
Patients who use the period of reduced appetite to develop sustainable eating habits and incorporate physical activity may be better positioned for long-term success. Resistance training and adequate protein intake are also important considerations because preserving lean muscle becomes particularly important during significant weight loss.
I tell patients at the start of treatment that medication is like having a skilled teammate. It can make certain aspects of weight management easier, but patients still need to participate actively in their treatment plan.
Misconception 2: Nausea Means the Medication Is Wrong for You
Nausea is a common side effect of GLP-1-based medications, particularly when treatment is first started or the dose is increased. This is one reason patients may become concerned that a medication is not suitable for them.
GLP-1 medications can affect appetite, gastrointestinal function, and the rate at which food leaves the stomach. These effects can contribute to nausea and other gastrointestinal symptoms, particularly during dose escalation.
Practical strategies may help some people manage mild nausea:
- Eat smaller meals and portions.
- Eat slowly.
- Avoid foods that personally worsen nausea or gastrointestinal discomfort.
- Maintain adequate hydration.
- Avoid lying down immediately after eating.
- Follow the dosing and titration instructions provided by the prescribing clinician.
For many patients, gastrointestinal side effects become less noticeable as the body adjusts. However, symptoms should not simply be ignored.
Persistent or severe nausea, repeated vomiting, difficulty maintaining hydration, severe or persistent abdominal pain, or other concerning symptoms should be discussed promptly with the prescribing healthcare professional.
The distinction between an expected side effect and a symptom requiring medical evaluation is important to understand before starting treatment.
Misconception 3: Faster Results Mean the Treatment Is Working Better
Patients who lose weight rapidly during the first weeks of treatment may assume that they are exceptional responders and that the same pace will continue. Patients who lose weight more slowly may instead worry that the medication is not working.
Neither assumption is necessarily correct.
Early changes in body weight can include changes in water and glycogen stores in addition to changes in body fat. The rate of weight loss may also slow as treatment continues. A slowdown does not automatically mean that treatment has failed.
Likewise, individual responses vary. Some patients may experience relatively gradual weight loss and still achieve meaningful results over a longer period.
The more useful measure is the overall trend in body weight and health over time rather than focusing on the change from one week to the next.
A patient who achieves consistent, sustainable progress over many months may ultimately have a better outcome than someone who experiences very rapid initial weight loss but cannot maintain the approach.
Misconception 4: Once You Reach Your Goal, You Stop the Medication
The belief that weight loss medication always has a defined endpoint is another common misunderstanding.
Obesity and excess weight can involve complex biological, behavioral, genetic, and environmental factors. For some patients, treatment may need to continue after the initial weight-loss phase to help maintain the benefits.
Research has found that significant weight regain can occur after discontinuation of some GLP-1-based weight-loss medications. This is one reason medication decisions should include a long-term maintenance plan rather than focusing only on reaching a target number on the scale.
This does not mean that every patient must remain on medication indefinitely. Some people may discontinue treatment under medical supervision, while others may benefit from longer-term therapy.
The appropriate approach depends on the individual’s health, response to treatment, side effects, goals, and preferences.
Patients considering different treatment options can also learn more about understanding weight loss medication and the factors that can influence medication selection.
Misconception 5: All Weight Loss Medications Are Basically the Same
The range of weight-loss medications has expanded significantly, and different medications can have important differences in their mechanisms, effectiveness, dosing schedules, side effects, contraindications, and approved uses.
Semaglutide and tirzepatide, for example, have different mechanisms even though both influence pathways involved in appetite and metabolism. Their average results and side-effect profiles can also differ.
The choice of medication should therefore be based on the patient’s overall clinical picture rather than assuming that every medication will produce the same result.
The field is also continuing to evolve, with additional medications and different therapeutic approaches being studied. New treatments may target pathways involving GLP-1, GIP, glucagon, amylin, and other biological mechanisms.
Patients who do not respond adequately to one medication should not automatically assume that every weight-loss medication will be ineffective for them. A clinician may evaluate the response, side effects, adherence, underlying health conditions, and other factors before deciding whether a different approach is appropriate.
Misconception 6: You Can Get Meaningful Results Without Adequate Protein Intake
This issue does not always receive enough attention in discussions about GLP-1 medications.
Because these medications can significantly reduce appetite, some patients may unintentionally consume much less food than before. If overall food intake becomes very low and protein intake is inadequate, some of the weight lost may come from lean tissue as well as body fat.
Preserving muscle during weight loss is important for strength, physical function, metabolic health, and long-term weight management.
Adequate protein intake combined with resistance training can help support the preservation of lean mass during weight loss. However, individual protein requirements vary based on body size, age, activity level, health conditions, and goals.
Rather than following a single protein target without considering individual circumstances, patients should discuss appropriate protein intake with their healthcare professional or a registered dietitian.
When appetite is very low or nausea makes eating difficult, nutrient-dense, protein-rich foods may be easier to incorporate in smaller portions. In some circumstances, a clinician or dietitian may also recommend a protein supplement.
The goal is not simply to lose weight but to improve body composition and preserve as much functional lean tissue as possible.
Starting With the Right Expectations
Weight loss medication is an important clinical tool for managing obesity and, in appropriate patients, can produce meaningful improvements in body weight and related health outcomes.
However, the patients who get the most from treatment are not necessarily those who lose the most weight during the first few weeks. They are often the people who begin treatment with realistic expectations, remain engaged with their healthcare team, follow the prescribed treatment plan, and make sustainable lifestyle changes alongside medication.
Correcting these misconceptions before treatment begins is not about lowering expectations. It is about setting accurate ones.
For people who are beginning their weight-management journey, learning about different methods to lose weight can help provide broader context about nutrition, physical activity, behavioral changes, and medical treatment.
Weight loss can also look very different from person to person. Public examples such as the John Cena weight loss journey may be interesting to read, but celebrity or athlete experiences should not be treated as a medical blueprint for everyone.
Ultimately, weight-loss medication works best when it is part of an individualized treatment plan. Understanding how the medication works, what side effects to expect, how to protect muscle mass, and what happens after the initial weight-loss phase can help patients make more informed decisions about their care.
Dr. Quoc N. Dang, DO, is a board-certified physician and Medical Director at WeightLossPills.com, where he specializes in medically supervised weight management and GLP-1 therapy.
